As a pioneer in applying generative AI to drug development, Insilico Medicine presents its leadership team and AI platform business development team at ARDD 2024, and industry partners are welcomed for communication and connection. (IMAGE)

InSilico Medicine

As a pioneer in applying generative AI to drug development, Insilico Medicine presents its leadership team and AI platform business development team at ARDD 2024, and industry partners are welcomed for communication and connection.

Caption

On August 27th, Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine, will deliver a keynote speech on "Methylation Clocks and AI Life Models as Sources of Therapeutic Targets" from 18:00-18:20 local time; Frank Pun, Ph.D., head of application science of Insilico Medicine, and Fedor Galkin, senior scientist at Insilico Medicine, will share the latest progress in their presentation "Dual-Purpose Target Discovery & Aging Research with PreciousGPT Models".

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.